“Since HDFC Bank is a darling of the market, the expectations were higher and the lower delivery led to harsh reactions,” said Siddhartha Khemka, head of research at Motilal Oswal Securities.
Vijay Kedia buys 9 lakh shares of SME stock Mahamaya Lifesciences in Rs 12.5 crore block deal
Ace investor Vijay Kedia acquired a significant stake in Mahamaya Lifesciences through a block deal. He purchased nearly 9 lakh shares at Rs 140 each.